QIAXTRACTOR
LIVE

Serial Number

79071657

Owner

QIAGEN GMBH

Attorney

Roxana A. Sullivan

Filing Date

Mar 20, 2009

Add to watchlist:

No watchlists yet
View on USPTO

QIAXTRACTOR Trademark

Serial Number: 79071657 • Registration: 3845402

QIAXTRACTOR is a trademark filed by QIAGEN GMBH on March 20, 2009. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

QIAGEN GMBH (212 trademarks)

HILDEN D-4010 , DE

Entity Type: 03

Corbett Research Pty Ltd (3 trademarks)

1/14 Hilly Street

Entity Type: 99

Trademark Details

Filing Date

March 20, 2009

Registration Date

September 7, 2010

Published for Opposition

June 22, 2010

Cancellation Date

March 20, 2019

Goods & Services

Scientific apparatus, instruments and equipment for scientific research, non-medical diagnostic analysis, chemical analysis, clinical analysis and industrial use, namely, nucleic acid purifiers, [ sequencers, polymerase chain reaction (PCR) cyclers, thermocyclers, electroporators, pipetting equipment, incubators, laboratory centrifuges; laboratory equipment ] and automated laboratory equipment, namely, apparatus for extraction, [ analysis and handling of nucleic acids, ] nucleic acid extractors and automated nucleic acid extractors; parts and accessories for the foregoing, namely, robotic parts, pumps, carbon-filter purifiers, waste collection apparatus and bottles, filter cartridges, UV light sterilizers, reagent tubs, sample containers, holders for containers, pipette tips, pipette tip holders, pipetting aides, microplates; computer software for operation and maintenance of scientific apparatus, instruments and equipment, namely, automated nucleic acid extractors; computer software for creating experimental profiles, providing experimental reports and reports of apparatus performance verification

[ Products for medical and veterinary medical purposes, in particular diagnostic preparations, in particular nucleic acids, enzymes, polymerases, reagents for staining and marking, molecular probes, buffer chemicals and aqueous and non- aqueous solutions of primary, secondary and tertiary alcohols and salts, distilled and purified water, magnetic particles in fluid form, and materials for reaction vessels for the purpose of purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, all of the foregoing for medical and veterinary purposes; products for medical and veterinary medical purposes, namely, chemical, biochemical and biotechnological products as well as kits comprising products for medical and veterinary medical purposes, in particular chemical, biochemical and biotechnological products for sample preparation, purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids for medical and veterinary medical purposes, enzymes, natural and artificial proteins, macro molecules, and biologically active substances for detecting pathogens, genetic information and conditions of the human body ]

[ Chemical, biochemical and biotechnological products for industrial and scientific purposes, in particular nucleic acids, enzymes, polymerases, reagents for staining and marking, molecular probes, buffer, aqueous and non-aqueous solutions of alcohols and salts, distilled and purified water, silica in powdered, granulate and gel form and magnetic particles in fluid form, none of the foregoing for medical or veterinary purposes; materials for columns and reagents and solvents for sample preparation, all of the foregoing for the purpose of purification, lysis, modification and manipulation of cells, as well as for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, none of the foregoing for medical or veterinary purposes; kits comprising chemical, biochemical and biotechnological products for sample preparation, purification, lysis, modification and manipulation of cells as well as for the performance of marking, separation, isolation, purification, amplification and analytical methods for biopolymers, in particular nucleic acids, enzymes, proteins, macro molecules and biologically active substances for separation, analysis and purification of biological and biochemical compounds, in particular nucleic acids made from biological and biochemical sample material, none of the foregoing for medical or veterinary purposes ]

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Oct 18, 2019 DENC
DEATH OF INTERNATIONAL REGISTRATION
Oct 18, 2019 DETH
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Sep 7, 2019 REM4
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jan 30, 2018 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 20, 2018 INPR
PARTIAL INVALIDATION PROCESSED BY THE IB
Jul 7, 2017 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
May 25, 2017 INPS
INVALIDATION PROCESSED
May 25, 2017 INPC
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 20, 2017 NA71
REGISTERED-SEC.71 ACCEPTED
May 20, 2017 71AG
CANCELLED SEC. 7 - PARTIAL
May 20, 2017 C7P.
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
May 16, 2017 INPR
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 15, 2017 APRE
NEW REPRESENTATIVE AT IB RECEIVED
Mar 10, 2017 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 9, 2017 NREP
RQST FOR SECT 7 PARTIAL SURRENDER FILED
Jan 24, 2017 C7PF
TEAS SECTION 7 SURRENDER RECEIVED
Jan 24, 2017 ES7S
NEW REPRESENTATIVE AT IB RECEIVED
Dec 16, 2016 NREP
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Sep 16, 2016 NA15
REGISTERED - SEC. 15 ACKNOWLEDGED
Sep 16, 2016 15AK
POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Sep 16, 2016 PR75
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 16, 2016 APRE
TEAS SECTION 71 & 15 RECEIVED
Aug 11, 2016 ES75
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 13, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 20, 2010 FICS
FINAL DISPOSITION PROCESSED
Dec 17, 2010 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 7, 2010 FICR
CHANGE OF OWNER RECEIVED FROM IB
Nov 27, 2010 CHLD
REGISTERED-PRINCIPAL REGISTER
Sep 7, 2010 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 22, 2010 NPUB
PUBLISHED FOR OPPOSITION
Jun 22, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 19, 2010 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 18, 2010 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 12, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 12, 2010 CRFA
ASSIGNED TO LIE
Apr 12, 2010 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 1, 2010 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 1, 2010 TROA
REFUSAL PROCESSED BY IB
Nov 13, 2009 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 5, 2009 RFCS
REFUSAL PROCESSED BY MPU
Oct 5, 2009 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 3, 2009 RFCR
NON-FINAL ACTION WRITTEN
Oct 2, 2009 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Sep 28, 2009 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 25, 2009 RFCR
NON-FINAL ACTION WRITTEN
Sep 24, 2009 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 15, 2009 MAFR
ASSIGNED TO EXAMINER
Sep 11, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 11, 2009 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 10, 2009 REPR